Clinical Trial Update: Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fidaxomicin versus vancomycin for Clostridioides difficile infection has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Dificid (fidaxomicin)
• Vancocin (vancomycin)

Snippet

Sponsor: Hartford Hospital | Conditions: Clostridium Difficile Infection | Phase 4 | Status: COMPLETED | Results posted: 2017-06-28